1. New developments in the management of diffuse large B-cell lymphoma;TM Habermann;Hematology (Amsterdam, Netherlands),2012
2. Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA;DS Mytelka;Hematology (Amsterdam, Netherlands),2015
3. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;LH Sehn;Journal of Clinical Oncology,2005
4. Maintenance Rituximab every 2 months for 2 years is effective and well tolerated in patients with follicular lymphoma with both standard or rapid infusion: Updated results from the phase IIIb MAXIMA study;R Foa;Onkologie,2011
5. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial;G Salles;Lancet,2011